Given the extreme level of support Aren't we just automatically assuming success ?
$ Nothing other than a routine quarterly since Sept 26 NR for trial update
$ Not a word from the globe's only phase III company for sepsis during the World Sepsis Day events
$ No interest in listing the 25M warrants that will expire on March 2 2014, and could potentially put $ 15M in SDI's daily cheqing account
$ No willingness to share the most positive details from the 2 separate analysts that have $5.40 and $1.40 targets on our share price
$ A lack of promotion, let's not discuss the last IR effort, the vision of a faulty one year chart is enough, not to mention the similar experiences I've endured elsewhere
$ The company is so tightly held, "if it were the beaver on a Canadian nickel, it would pinch a loaf"
$$$ Hang tough folks, I remember the great Square pointing out that the first two FDA successes ( our CEO is 2-0 when it comes to FDA submissions ) saw record low share prices prior to the answer being revealed.
The US listing is the KEY, right now the DIAGF symbol would attract virtually nothing in the way of BIG US money, just wait until we hit a real exchange ( see Novadaq ), the stock is at the bottom, and not a soul is concerned, hold it and get more if you can - IMHO
Schemer